SurgoCap Partners LP reduced its stake in Hilton Worldwide Holdings Inc. (NYSE:HLT) by 13.8% in the fourth quarter, selling 80,953 shares but retaining a significant holding of 503,719 shares valued at $144.7 million. Despite this sale, institutional investors continue to hold 95.9% of the stock, while Wall Street analysts maintain a "Moderate Buy" rating with a consensus price target of $349.45. Hilton also announced a quarterly dividend of $0.15 per share and beat quarterly EPS estimates.

Bristol Myers Squibb (BMY) stock is gaining attention after expanding its kidney cancer trial, adding new casdatifan arms to the ROSETTA RCC-208 study through a collaboration with Arcus Biosciences. Despite mixed recent performance, the stock is considered 10.7% undervalued with a fair value of $62.96, though it faces risks from upcoming patent expiries and potential underperformance of new launches. Investors are evaluating whether the current trading price of $56.24, which offers a 4.5% dividend yield, represents a mispricing or if future growth is already factored in.

Duke Energy (DUK) is under fresh scrutiny after receiving a US$61.8 million DOE grant to refurbish coal-fired plants, with its stock currently trading at US$125.28. While a common narrative suggests the stock is 9.6% undervalued based on long-term power demand and capital plans, Simply Wall St's DCF model indicates it might be overvalued at its current price. Investors are advised to consider both the optimistic outlook from strong regional growth and the potential risks from customer-owned solar and increased capital costs, as well as the contrasting fair value assessments.

Warpaint London PLC reported improved trading in the second quarter of 2026 and announced a new US partnership with Ulta Beauty, enabling the launch of an online Christmas gift range. The cosmetics group maintained its full-year forecasts, expecting sales to be more weighted towards the second half of the year due to larger orders, including a significant Christmas order from Walmart, and customer rollouts. Warpaint also highlighted a strong balance sheet with £20.6 million in cash and a new consultancy agreement aimed at accelerating growth.

SITIME Corp CEO Rajesh Vashist sold 20,000 shares of common stock in open-market transactions. The sale included 5,000 indirectly held shares at $750.00 each and 15,000 directly held shares at $750.20 each, totaling $15,003,000. Following these transactions, Vashist directly holds 387,898 shares and indirectly holds 9,781 shares, with an additional 291,529 shares issuable from unvested restricted stock units.

Soleno Therapeutics presented new data at ENDO 2026 showing that VYKAT® XR (diazoxide choline) provides meaningful and durable improvements in hyperphagia and behavioral symptoms in patients with Prader-Willi Syndrome (PWS), even after a randomized withdrawal period. Participants who resumed treatment experienced improvements as early as Week 13, continuing for up to two years. The data also highlighted sustained benefits for up to three years compared to real-world information from the PATH for PWS Natural History Study.

This article provides analyst insights on two utilities companies: Avista (AVA) and Vistra Corp (VST). Bank of America Securities maintained a Sell rating on Avista with a $37.00 price target, while Wells Fargo assigned a Buy rating to Vistra Corp with a $259.00 price target. The consensus for Avista is a Hold, and for Vistra Corp, it is a Strong Buy.

Procter & Gamble (P&G) is reportedly reshuffling its executive team under the leadership of its new CEO, Shailesh Jejurikar. This reorganization includes new appointments to four of P&G's five business segments. The changes see new CEOs for grooming, beauty, health care, and baby, feminine & family care divisions, as the company continues its restructuring plan which includes job cuts and brand divestments.

AT&T shares fell 1.23% on Monday, closing at $23.29, despite a broader market rally, as investors rotated out of telecom stocks ahead of the Federal Reserve's rate decision. The company's stock, along with other telecom names, was sensitive to interest rate changes and lagged growth-oriented tech stocks. Investors are now looking to AT&T's upcoming Q2 earnings call on July 22 for updates on free cash flow, fiber growth, and postpaid phone metrics, which will be crucial in addressing concerns about the company's significant debt load and capital expenditures.

Faithward Advisors LLC significantly reduced its stake in Generac Holdings Inc. by 29.9% in the fourth quarter, selling over 8,000 shares. This move comes as Generac insiders, including the CEO, have also sold shares. Despite these sales, analysts generally maintain a "Moderate Buy" rating for Generac, with the company recently exceeding quarterly EPS and revenue expectations.